Science Explorer Back to mapMap
Discussion
Researcher · Siemens Healthcare (United States) · United States

Harry R. Leipold

Harry R. Leipold publishes mostly in Molecular Biology, Pharmaceutical Science and Cell Biology, on topics such as Advanced Biosensing Techniques and Applications, Proteoglycans and glycosaminoglycans research and Metabolomics and Mass Spectrometry Studies.

OpenAlex
World rank
#4,615,180
of 7,710,434 ranked researchers
Rank in United States
#1,220,817
of 1,627,098
Works
51
Citations
488
Citations per work
9.6
h-index
11
i10-index 11Top 71% in Molecular Biology
Harry R. Leipold

What does Harry R. Leipold research?

Harry R. Leipold's work is mostly in Biochemistry, Genetics and Molecular Biology (26%), Medicine (11%), Pharmacology, Toxicology and Pharmaceutics (7%).

Everything else: 26 works · 50.9% of their workLife Sciences: 17 works · 33.0% of their workBiochemistry, Genetics and Molecular Biology: 13 works · 26.2% of their workMolecular Biology: 10 works · 20.3% of their workCell Biology: 3 works · 5.9% of their workPharmacology, Toxicology and Pharmaceutics: 3 works · 6.8% of their workPharmaceutical Science: 3 works · 6.8% of their workHealth Sciences: 6 works · 11.0% of their workMedicine: 6 works · 11.0% of their workEndocrinology, Diabetes and Metabolism: 3 works · 5.9% of their workEpidemiology: 3 works · 5.1% of their workPhysical Sciences: 3 works · 5.1% of their workChemistry: 3 works · 5.1% of their workSpectroscopy: 3 works · 5.1% of their workTHEIR WORKHarry R. Leipold51works
Life Sciences33%Physical Sciences5%Health Sciences11%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else2650.9%
    1. Biochemistry, Genetics and Molecular Biology1326.2%
    2. Pharmacology, Toxicology and Pharmaceutics36.8%
    1. Medicine611.0%
    1. Chemistry35.1%
  1. 1Molecular Biology20% of their works
  2. 2Pharmaceutical Science7% of their works
  3. 3Cell Biology6% of their works
  4. 4Endocrinology, Diabetes and Metabolism6% of their works
  5. 5Epidemiology5% of their works
  6. 6Spectroscopy5% of their works

Research topics

Which keywords describe Harry R. Leipold's research?

The keywords of their largest research topics: Mass Spectrometry, Angiogenesis, Inflammation, High-Throughput Analysis, Protein Microarrays, Data Analysis, Hyaluronan and Metabolomics.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Mass Spectrometry112 topics
  2. Angiogenesis102 topics
  3. Inflammation102 topics
  4. High-Throughput Analysis71 topic
  5. Protein Microarrays71 topic
  6. Data Analysis61 topic
  7. Hyaluronan61 topic
  8. Metabolomics61 topic
  9. Proteoglycans61 topic
  10. Chitosan51 topic
  11. Green Analytical Chemistry51 topic
  12. Hormone Therapy51 topic
  13. Nanoparticles51 topic
  14. Pharmaceutical Analysis51 topic
  15. Proteomics51 topic
  16. Quantitative Analysis51 topic
  17. Testosterone51 topic
  18. Cell Adhesion41 topic
  19. Integrins41 topic

Where does Harry R. Leipold work?

Harry R. Leipold's main affiliation in the publication record is Siemens Healthcare (United States), United States.

How many publications and citations does Harry R. Leipold have?

OpenAlex counts 51 works and 488 citations for Harry R. Leipold, an h-index of 11, ranking #4,615,180 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Harry R. Leipold. Posts are plain text and can be reported.